141 related articles for article (PubMed ID: 12038700)
1. Cardiac disease in diabetic patients with renal disease.
Foley R
Acta Diabetol; 2002 Apr; 39 Suppl 1():S9-14. PubMed ID: 12038700
[TBL] [Abstract][Full Text] [Related]
2. Cardiac disease in diabetic end-stage renal disease.
Foley RN; Culleton BF; Parfrey PS; Harnett JD; Kent GM; Murray DC; Barre PE
Diabetologia; 1997 Nov; 40(11):1307-12. PubMed ID: 9389423
[TBL] [Abstract][Full Text] [Related]
3. Electrocardiographic abnormalities among dialysis naïve chronic kidney disease patients in Ilorin Nigeria.
Chijioke A; Makusidi AM; Kolo PM
Ann Afr Med; 2012; 11(1):21-6. PubMed ID: 22199043
[TBL] [Abstract][Full Text] [Related]
4. Differences in the patterns of age-specific black/white comparisons between end-stage renal disease attributed and not attributed to diabetes.
Lopes AA; Port FK
Am J Kidney Dis; 1995 May; 25(5):714-21. PubMed ID: 7747725
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
Lajer M; Tarnow L; Jorsal A; Teerlink T; Parving HH; Rossing P
Diabetes Care; 2008 Apr; 31(4):747-52. PubMed ID: 18162497
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
Fragoso A; Mendes F; Silva AP; Neves PL
J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular hypertrophy in African Black patients with chronic renal failure at first evaluation.
Ulasi II; Arodiwe EB; Ijoma CK
Ethn Dis; 2006; 16(4):859-64. PubMed ID: 17061738
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular diastolic dysfunction in patients with chronic renal failure: impact of diabetes mellitus.
Miyazato J; Horio T; Takiuchi S; Kamide K; Sasaki O; Nakamura S; Nakahama H; Inenaga T; Takishita S; Kawano Y
Diabet Med; 2005 Jun; 22(6):730-6. PubMed ID: 15910624
[TBL] [Abstract][Full Text] [Related]
9. Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis.
O'Shaughnessy MM; Liu S; Montez-Rath ME; Lafayette RA; Winkelmayer WC
Eur Heart J; 2019 Mar; 40(11):887-898. PubMed ID: 30085056
[TBL] [Abstract][Full Text] [Related]
10. Revisiting racial differences in ESRD due to ADPKD in the United States.
Murphy EL; Dai F; Blount KL; Droher ML; Liberti L; Crews DC; Dahl NK
BMC Nephrol; 2019 Feb; 20(1):55. PubMed ID: 30764782
[TBL] [Abstract][Full Text] [Related]
11. Racial differences in the incidence of end-stage renal disease.
Tell GS; Hylander B; Craven TE; Burkart J
Ethn Health; 1996 Mar; 1(1):21-31. PubMed ID: 9395545
[TBL] [Abstract][Full Text] [Related]
12. Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure.
Foley RN
Semin Dial; 2003; 16(2):111-7. PubMed ID: 12641874
[TBL] [Abstract][Full Text] [Related]
13. [Cardiovascular protection of diabetic patient with chronic renal disease and particular case of end-stage renal disease in elderly patients].
Zaoui P; Hannedouche T; Combe C
Nephrol Ther; 2017 Jun; 13(6S):6S16-6S24. PubMed ID: 29463395
[TBL] [Abstract][Full Text] [Related]
14. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
[TBL] [Abstract][Full Text] [Related]
15. [Diabetes, obesity and heart complications].
Picard F; dos Santos P; Catargi B
Rev Prat; 2013 Jun; 63(6):759-64. PubMed ID: 23923748
[TBL] [Abstract][Full Text] [Related]
16. Racial factors in the incidence and causation of end-stage renal disease (ESRD).
Easterling RE
Trans Am Soc Artif Intern Organs; 1977; 23():28-33. PubMed ID: 910346
[TBL] [Abstract][Full Text] [Related]
17. Selection of the dose of angiotensin converting enzyme inhibitor for patients with diabetic nephropathy depends on the presence or absence of left ventricular hypertrophy.
Suzuki H; Kanno Y; Ikeda N; Nakamoto H; Okada H; Sugahara S
Hypertens Res; 2002 Nov; 25(6):865-73. PubMed ID: 12484510
[TBL] [Abstract][Full Text] [Related]
18. Concomitant macro and microvascular complications in diabetic nephropathy.
Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of lower-extremity amputation among Caucasian diabetic patients on dialysis.
Morbach S; Quante C; Ochs HR; Gaschler F; Pallast JM; Knevels U
Diabetes Care; 2001 Sep; 24(9):1689-90. PubMed ID: 11522723
[No Abstract] [Full Text] [Related]
20. Vascular complications of the lower extremities in diabetic patients on peritoneal dialysis.
Pliakogiannis T; Bailey S; Cherukuri S; Taskapan H; Ahmad M; Oliver T; Bargman JM; Oreopoulos DG
Clin Nephrol; 2008 May; 69(5):361-7. PubMed ID: 18538099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
